An accomplished leader of several medical-device companies in women’s healthcare, Mr. Gex previously served as Chairman and CEO of BioLucent, Inc., manufacturer of the MammoPad® breast cushion to reduce mammography discomfort, which was acquired in September 2007 by Hologic, Inc. Prior to BioLucent, Mr. Gex co-founded and served as President and CEO of Biopsys Medical, Inc., the maker of Mammotome®, a non-surgical breast biopsy device used to diagnose breast cancer. At Biopsys, Mr. Gex guided the company’s initial public offering and subsequent sale to Johnson & Johnson in 1997. He has also served on the boards of directors for several other medical device companies such as Opus Medical, VivaRay, Cianna Medical and Cayenne Medical. Mr. Gex received a B.S. in Business Marketing from San Diego State University.
A graduate of Stanford University in Mechanical Engineering, Mr. Hermann began his medical device career in 1983 working directly with surgeon inventor and entrepreneur Thomas Fogarty, MD. During his 18 year tenure with Dr. Fogarty and thereafter, Mr. Hermann has been operationally responsible for the development of more than 20 commercially successful medical product families in urology, cardiac and vascular surgery, general surgery, radiology, radiation oncology and women’s health. He has been a founder, board member and/or president of a variety of medical device startups that were acquired by Medtronic, Covidien, Johnson & Johnson, Hologic, Microline Pentax and Varian Medical Systems. Mr. Hermann is an inventor on more than 200 patents and patent applications and is an author of more than 50 scientific presentations on medical device technology.
Mr. Naber has been involved with the financing and operations of 14 medical device companies over the past 24 years. From October 1998, he served as the Chief Financial Officer of eyeonics, inc. until its acquisition by Bausch & Lomb in 2008. Subsequent to the acquisition he held operational and financial roles with Bausch & Lomb Surgical, Vertos Medical, Inc., Orthalign, Inc., Bone-Rad Therapeutics and CXL Ophthalmics. From 1999-2002, while serving as the CFO of eyeonics, Mr. Naber also served as a consultant to four Orange County medical device start-up companies. Intralase went public in 2004 and was subsequently sold to Advanced Medical Optics. SenoRx also went public in 2004 and was acquired by C.R. Bard, Inc. BioLucent was acquired by Hologic, Inc. in 2007, and Vascular Control Systems was acquired by Johnson & Johnson in 2003. From 1995 until 1997 Mr. Naber served as Vice President, Finance and Chief Financial Officer of Biopsys Medical, Inc., a publicly-held medical device company, which was acquired by Johnson & Johnson. From 1991 to 1995, Mr. Naber served as the Chief Financial Officer of Smith & Nephew’s ophthalmic division which was acquired by Allergan, Inc. Mr. Naber received a B.B.A. in Accounting from the University of Iowa.
Mr. Beney has more than 30 years of experience in sales, sales management, and senior sales leadership positions within the medical device industry. He served as Vice President of Sales at Scion Medical Technologies, marketer of ultrasound guided breast biopsy devices, Vice President of International Sales and Business Development at Cianna Medical, a company which focused on women’s health and the innovative treatment of early-stage breast cancer. Previous to Cianna, Mr. Beney served as the Vice President of Sales and Marketing for Intact Medical Corporation, a manufacturer and marketer of the Intact breast biopsy device. Mr. Beney also served as the National Sales Manager for the Breast Care division of Ethicon Endosurgery (Biopsys), paving the way for the advent of vacuum-assisted core biopsy and the replacement of fine needle aspiration as the standard of care in breast biopsy. In addition to Mr. Beney’s extensive experience in the breast care field, he has also held executive management positions with Conceptus, Neurometrix and Scimed Life Systems. Mr. Beney earned his Bachelor of Arts degree in Advertising from Michigan State University.
Recognized internationally for her pioneering clinical work as an oncoplastic breast surgeon, Dr. Lebovic has collaborated with Mr. Hermann and Dr. Fogarty on a variety of projects in the field of women’s healthcare. She has served as founder/board member/medical director and consultant for many medical device companies and has a long track record of successful commercialization and acceptance of products into clinical practice. She is well known as an inventor of the MammoPad® breast cushion as well as other popular, innovative devices. Dr. Lebovic spent 12 years as an attending surgeon at Stanford University Medical Center and later served as Associate Director of the Lee Breast Center at USC and Director of Women’s Healthcare at the Cooper Clinic in Dallas, Texas. She has lectured extensively throughout the world, and has authored numerous scientific publications. Her leadership roles in various philanthropic endeavors have been an important part of her career, and she has recently completed a two-year term as President of the American Society of Breast Disease.
Mr. Driscoll has nearly 20 years experience in the development, sales and marketing of medical devices. Prior to Focal Therapeutics, he led the commercialization of the SAVI® breast brachytherapy applicator as Vice President of Marketing for Cianna Medical. Mr. Driscoll’s previous experience includes serving as Senior Product Manager at Interpore Cross International, a leading manufacturer of biologic and spinal implants. Prior to that, he held various senior sales and marketing positions at other medical devices manufacturers, including Silipos, Inc. and Innovation Sports, Inc. Mr. Driscoll earned his B.S. in Health Education from the University of Cincinnati.